Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

High CC chemokine receptor 7 expression improves postoperative prognosis of lung adenocarcinoma patients.

Itakura M, Terashima Y, Shingyoji M, Yokoi S, Ohira M, Kageyama H, Matui Y, Yoshida Y, Ashinuma H, Moriya Y, Tamura H, Harigaya K, Matushima K, Iizasa T, Nakagawara A, Kimura H.

Br J Cancer. 2013 Sep 3;109(5):1100-8. doi: 10.1038/bjc.2013.440. Epub 2013 Aug 6.

PMID:
23922113
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.

Zhang Y, Sun Y, Li Y, Fang Z, Wang R, Pan Y, Hu H, Luo X, Ye T, Li H, Wang L, Chen H, Ji H.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S577-82. doi: 10.1245/s10434-013-3027-1. Epub 2013 Jun 18.

PMID:
23775406
[PubMed - indexed for MEDLINE]
3.

BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutations.

Karachaliou N, Costa C, Gimenez-Capitan A, Molina-Vila MA, Bertran-Alamillo J, Mayo C, Massuti B, Majem M, Carcereny E, Moran T, Sanchez JJ, Viteri S, Gasco A, Wannesson L, Souglakos J, Jimeno J, Rosell R; Spanish Lung Cancer Group.

J Thorac Oncol. 2013 Mar;8(3):295-300. doi: 10.1097/JTO.0b013e31827db621.

PMID:
23407556
[PubMed - indexed for MEDLINE]
4.

Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients.

Ishikawa M, Sonobe M, Nakayama E, Kobayashi M, Kikuchi R, Kitamura J, Imamura N, Date H.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S467-76. doi: 10.1245/s10434-012-2795-3. Epub 2012 Dec 16.

PMID:
23242819
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma.

Kosaka T, Yatabe Y, Onozato R, Kuwano H, Mitsudomi T.

J Thorac Oncol. 2009 Jan;4(1):22-9. doi: 10.1097/JTO.0b013e3181914111.

PMID:
19096302
[PubMed - indexed for MEDLINE]
6.

Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.

Wang J, Seethala RR, Zhang Q, Gooding W, van Waes C, Hasegawa H, Ferris RL.

J Natl Cancer Inst. 2008 Apr 2;100(7):502-12. doi: 10.1093/jnci/djn059. Epub 2008 Mar 25.

PMID:
18364504
[PubMed - indexed for MEDLINE]
Free Article
7.

High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.

Gately K, Forde L, Cuffe S, Cummins R, Kay EW, Feuerhake F, O'Byrne KJ.

Clin Lung Cancer. 2014 Jan;15(1):58-66. doi: 10.1016/j.cllc.2013.08.005. Epub 2013 Nov 7.

PMID:
24210543
[PubMed - indexed for MEDLINE]
8.

Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma.

Maekawa S, Iwasaki A, Shirakusa T, Kawakami T, Yanagisawa J, Tanaka T, Shibaguchi H, Kinugasa T, Kuroki M, Kuroki M.

Oncol Rep. 2008 Jun;19(6):1461-8.

PMID:
18497951
[PubMed - indexed for MEDLINE]
9.

Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.

Nose N, Sugio K, Oyama T, Nozoe T, Uramoto H, Iwata T, Onitsuka T, Yasumoto K.

J Clin Oncol. 2009 Jan 20;27(3):411-7. doi: 10.1200/JCO.2008.18.3251. Epub 2008 Dec 8.

PMID:
19064969
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.

Hyogotani A, Ito K, Yoshida K, Izumi H, Kohno K, Amano J.

Clin Lung Cancer. 2012 Sep;13(5):375-84. doi: 10.1016/j.cllc.2011.11.006. Epub 2012 Jan 27.

PMID:
22284440
[PubMed - indexed for MEDLINE]
12.

Epidermal growth factor receptor-related tumor markers and clinical outcomes with erlotinib in non-small cell lung cancer: an analysis of patients from german centers in the TRUST study.

Schneider CP, Heigener D, Schott-von-Römer K, Gütz S, Laack E, Digel W, Guschall WR, Franke A, Bodenstein H, Schmidtgen C, Reck M.

J Thorac Oncol. 2008 Dec;3(12):1446-53. doi: 10.1097/JTO.0b013e31818ddcaa.

PMID:
19057271
[PubMed - indexed for MEDLINE]
13.

Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.

Lee JG, Kim S, Shim HS.

Lung Cancer. 2012 Jul;77(1):156-61. doi: 10.1016/j.lungcan.2012.02.013. Epub 2012 Mar 13.

PMID:
22418245
[PubMed - indexed for MEDLINE]
14.

Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.

Yanagawa N, Leduc C, Kohler D, Saieg MA, John T, Sykes J, Yoshimoto M, Pintilie M, Squire J, Shepherd FA, Tsao MS.

J Thorac Oncol. 2012 Oct;7(10):1513-21.

PMID:
22982652
[PubMed - indexed for MEDLINE]
15.

Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).

Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, Tan L, Agasthian T, Koong HN, Tam J, Tan C, Caleb M, Chang A, Ng A, Tan P.

J Thorac Oncol. 2009 Jan;4(1):12-21. doi: 10.1097/JTO.0b013e3181913e28.

PMID:
19096301
[PubMed - indexed for MEDLINE]
16.

Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.

Wang Y, Dong QZ, Fu L, Stoecker M, Wang E, Wang EH.

Mol Carcinog. 2013 Nov;52(11):890-9. doi: 10.1002/mc.21935. Epub 2012 Jun 29.

PMID:
22753141
[PubMed - indexed for MEDLINE]
17.

The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis.

Oliveira-Neto HH, de Souza PP, da Silva MR, Mendonça EF, Silva TA, Batista AC.

Tumour Biol. 2013 Feb;34(1):65-70. doi: 10.1007/s13277-012-0511-3. Epub 2012 Sep 14.

PMID:
22976543
[PubMed - indexed for MEDLINE]
18.

Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.

Cassier PA, Treilleux I, Bachelot T, Ray-Coquard I, Bendriss-Vermare N, Ménétrier-Caux C, Trédan O, Goddard-Léon S, Pin JJ, Mignotte H, Bathélémy-Dubois C, Caux C, Lebecque S, Blay JY.

BMC Cancer. 2011 May 30;11:213. doi: 10.1186/1471-2407-11-213.

PMID:
21624121
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.

Wang R, Geng J, Wang JH, Chu XY, Geng HC, Chen LB.

Lung Cancer. 2009 Nov;66(2):237-44. doi: 10.1016/j.lungcan.2009.02.001. Epub 2009 Mar 3.

PMID:
19261348
[PubMed - indexed for MEDLINE]
20.

CCR7 and VEGF-C: molecular indicator of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?

Song Y, Wang Z, Liu X, Jiang W, Shi M.

Ann Surg Oncol. 2012 Oct;19(11):3606-12. doi: 10.1245/s10434-012-2419-y. Epub 2012 May 30.

PMID:
22644515
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk